CHAPTER 1. Industry Overview of Male Infertility Market
1.1. Definition and Scope
1.1.1. Definition of Male Infertility
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Male Infertility Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Male Infertility Market By Test
1.2.3. Male Infertility Market By Treatment
1.2.4. Male Infertility Market By End-User
1.2.5. Male Infertility Market By Region
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restraint 1
3.2.2. Restraint 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Male Infertility Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Male Infertility Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Regulatory Compliance
3.9. Competitive Landscape, 2021
3.9.1. Player Positioning Analysis
3.9.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Male Infertility Market By Test
4.1. Introduction
4.2. Male InfertilityRevenueBy Test
4.2.1. Male Infertility Revenue (US$ Mn) and Forecast, By Test, 2018-2030
4.2.2. Oxidative Stress Analysis
4.2.2.1. Oxidative Stress Analysis Market Revenue (US$ Mn) and Growth Rate (%), 2018-2030
4.2.3. DNA Fragmentation Technique
4.2.3.1. DNA Fragmentation Technique Market Revenue (US$ Mn) and Growth Rate (%), 2018-2030
4.2.4. Microscopic Examination
4.2.4.1. Microscopic Examination Market Revenue (US$ Mn) and Growth Rate (%), 2018-2030
4.2.5. Sperm Agglutination
4.2.5.1. Sperm Agglutination Market Revenue (US$ Mn) and Growth Rate (%), 2018-2030
4.2.6. Computer Assisted Semen Analysis
4.2.6.1. Computer Assisted Semen Analysis Market Revenue (US$ Mn) and Growth Rate (%), 2018-2030
4.2.7. Sperm Penetration Assay
4.2.7.1. Sperm Penetration Assay Market Revenue (US$ Mn) and Growth Rate (%), 2018-2030
4.2.8. Others
4.2.8.1. Others Market Revenue (US$ Mn) and Growth Rate (%), 2018-2030
CHAPTER 5. Male Infertility Market By Treatment
5.1. Introduction
5.2. Male Infertility Revenue (US$ Mn) By Treatment
5.2.1. Male Infertility Revenue (US$ Mn) and Forecast By Treatment, 2018-2030
5.2.2. Assisted Reproductive Technology and Varicocele Surgery
5.2.2.1. Assisted Reproductive Technology and Varicocele SurgeryMarket Revenue (US$ Mn) and Growth Rate (%), 2018-2030
5.2.3. Medication
5.2.3.1. Medication Market Revenue (US$ Mn) and Growth Rate (%), 2018-2030
CHAPTER 6. Male Infertility Market By End-User
6.1. Introduction
6.2. Male Infertility Revenue (US$ Mn) By End-User
6.2.1. Male Infertility Revenue (US$ Mn) and Forecast By End-User, 2018-2030
6.2.2. Hospitals & Clinics
6.2.2.1. Hospitals & Clinics Market Revenue (US$ Mn) and Growth Rate (%), 2018-2030
6.2.3. Fertility Centers
6.2.3.1. Fertility Centers Market Revenue (US$ Mn) and Growth Rate (%), 2018-2030
6.2.4. Research Institutes
6.2.4.1. Research Institutes Market Revenue (US$ Mn) and Growth Rate (%), 2018-2030
6.2.5. Others
6.2.5.1. Others Market Revenue (US$ Mn) and Growth Rate (%), 2018-2030
CHAPTER 7. North AmericaMale Infertility Market By Country
7.1. North America Male InfertilityOverview
7.2. U.S.
7.2.1. U.S. Male Infertility Revenue (US$ Mn) and Forecast By Test, 2018-2030
7.2.2. U.S. Male Infertility Revenue (US$ Mn) and Forecast By Treatment, 2018-2030
7.2.3. U.S. Male Infertility Revenue (US$ Mn) and Forecast ByEnd-User, 2018-2030
7.3. Canada
7.3.1. Canada Male Infertility Revenue (US$ Mn) and Forecast By Test, 2018-2030
7.3.2. Canada Male Infertility Revenue (US$ Mn) and Forecast By Treatment, 2018-2030
7.3.3. Canada Male Infertility Revenue (US$ Mn) and Forecast ByEnd-User, 2018-2030
7.4. North America PEST Analysis
CHAPTER 8. Europe Male Infertility Market By Country
8.1. Europe Male InfertilityOverview
8.2. U.K.
8.2.1. U.K.Male Infertility Revenue (US$ Mn) and Forecast By Test, 2018-2030
8.2.2. U.K. Male Infertility Revenue (US$ Mn) and Forecast By Treatment, 2018-2030
8.2.3. U.K. Male Infertility Revenue (US$ Mn) and Forecast ByEnd-User, 2018-2030
8.3. Germany
8.3.1. Germany Male Infertility Revenue (US$ Mn) and Forecast By Test, 2018-2030
8.3.2. Germany Male Infertility Revenue (US$ Mn) and Forecast By Treatment, 2018-2030
8.3.3. Germany Male Infertility Revenue (US$ Mn) and Forecast ByEnd-User, 2018-2030
8.4. France
8.4.1. France Male Infertility Revenue (US$ Mn) and Forecast By Test, 2018-2030
8.4.2. France Male Infertility Revenue (US$ Mn) and Forecast By Treatment, 2018-2030
8.4.3. France Male Infertility Revenue (US$ Mn) and Forecast ByEnd-User, 2018-2030
8.5. Spain
8.5.1. Spain Male Infertility Revenue (US$ Mn) and Forecast By Test, 2018-2030
8.5.2. Spain Male Infertility Revenue (US$ Mn) and Forecast By Treatment, 2018-2030
8.5.3. Spain Male Infertility Revenue (US$ Mn) and Forecast ByEnd-User, 2018-2030
8.6. Rest of Europe
8.6.1. Rest of Europe Male Infertility Revenue (US$ Mn) and Forecast By Test, 2018-2030
8.6.2. Rest of Europe Male Infertility Revenue (US$ Mn) and Forecast By Treatment, 2018-2030
8.6.3. Rest of Europe Male Infertility Revenue (US$ Mn) and Forecast ByEnd-User, 2018-2030
8.7. Europe PEST Analysis
CHAPTER 9. Asia Pacific Male Infertility Market By Country
9.1. Asia Pacific Male InfertilityOverview
9.2. China
9.2.1. China Male Infertility Revenue (US$ Mn) and Forecast By Test, 2018-2030
9.2.2. China Male Infertility Revenue (US$ Mn) and Forecast By Treatment, 2018-2030
9.2.3. China Male Infertility Revenue (US$ Mn) and Forecast ByEnd-User, 2018-2030
9.3. Japan
9.3.1. Japan Male Infertility Revenue (US$ Mn) and Forecast By Test, 2018-2030
9.3.2. Japan Male Infertility Revenue (US$ Mn) and Forecast By Treatment, 2018-2030
9.3.3. Japan Male Infertility Revenue (US$ Mn) and Forecast ByEnd-User, 2018-2030
9.4. India
9.4.1. India Male Infertility Revenue (US$ Mn) and Forecast By Test, 2018-2030
9.4.2. India Male Infertility Revenue (US$ Mn) and Forecast By Treatment, 2018-2030
9.4.3. India Male Infertility Revenue (US$ Mn) and Forecast ByEnd-User, 2018-2030
9.5. Australia
9.5.1. Australia Male Infertility Revenue (US$ Mn) and Forecast By Test, 2018-2030
9.5.2. Australia Male Infertility Revenue (US$ Mn) and Forecast By Treatment, 2018-2030
9.5.3. Australia Male Infertility Revenue (US$ Mn) and Forecast ByEnd-User, 2018-2030
9.6. South Korea
9.6.1. South Korea Male Infertility Revenue (US$ Mn) and Forecast By Test, 2018-2030
9.6.2. South Korea Male Infertility Revenue (US$ Mn) and Forecast By Treatment, 2018-2030
9.6.3. South Korea Male Infertility Revenue (US$ Mn) and Forecast ByEnd-User, 2018-2030
9.7. Rest of Asia-Pacific
9.7.1. Rest of Asia-PacificMale Infertility Revenue (US$ Mn) and Forecast By Test, 2018-2030
9.7.2. Rest of Asia-Pacific Male Infertility Revenue (US$ Mn) and Forecast By Treatment, 2018-2030
9.7.3. Rest of Asia-Pacific Male Infertility Revenue (US$ Mn) and Forecast ByEnd-User, 2018-2030
9.8. Asia Pacific PEST Analysis
CHAPTER 10. Latin America Male Infertility Market By Country
10.1. Latin AmericaMale InfertilityOverview
10.2. Brazil
10.2.1. Brazil Male Infertility Revenue (US$ Mn) and Forecast By Test, 2018-2030
10.2.2. Brazil Male Infertility Revenue (US$ Mn) and Forecast By Treatment, 2018-2030
10.2.3. Brazil Male Infertility Revenue (US$ Mn) and Forecast ByEnd-User, 2018-2030
10.3. Mexico
10.3.1. MexicoMale Infertility Revenue (US$ Mn) and Forecast By Test, 2018-2030
10.3.2. Mexico Male Infertility Revenue (US$ Mn) and Forecast By Treatment, 2018-2030
10.3.3. Mexico Male Infertility Revenue (US$ Mn) and Forecast ByEnd-User, 2018-2030
10.4. Rest of Latin America
10.4.1. Rest of Latin AmericaMale Infertility Revenue (US$ Mn) and Forecast By Test, 2018-2030
10.4.2. Rest of Latin America Male Infertility Revenue (US$ Mn) and Forecast By Treatment, 2018-2030
10.4.3. Rest of Latin America Male Infertility Revenue (US$ Mn) and Forecast ByEnd-User, 2018-2030
10.5. Latin America PEST Analysis
CHAPTER 11. Middle East & Africa Male Infertility Market By Country
11.1. Middle East & Africa Male InfertilityOverview
11.2. GCC
11.2.1. GCCMale Infertility Revenue (US$ Mn) and Forecast By Test, 2018-2030
11.2.2. GCC Male Infertility Revenue (US$ Mn) and Forecast By Treatment, 2018-2030
11.2.3. GCC Male Infertility Revenue (US$ Mn) and Forecast ByEnd-User, 2018-2030
11.3. South Africa
11.3.1. South AfricaMale Infertility Revenue (US$ Mn) and Forecast By Test, 2018-2030
11.3.2. GCC Male Infertility Revenue (US$ Mn) and Forecast By Treatment, 2018-2030
11.3.3. GCCMale Infertility Revenue (US$ Mn) and Forecast ByEnd-User, 2018-2030
11.4. Rest of Middle East & Africa
11.4.1. Rest of Middle East & AfricaMale Infertility Revenue (US$ Mn) and Forecast By Test, 2018-2030
11.4.2. Rest of Middle East & Africa Male Infertility Revenue (US$ Mn) and Forecast By Treatment, 2018-2030
11.4.3. Rest of Middle East & Africa Male Infertility Revenue (US$ Mn) and Forecast ByEnd-User, 2018-2030
11.5. Middle East & Africa PEST Analysis
CHAPTER 12. Player Analysis Of Male Infertility Market
12.1. Male Infertility MarketCompany Share Analysis
12.2. Competition Matrix
12.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
12.2.2. New Product Launches and Product Enhancements
12.2.3. Mergers And Acquisition InGlobal Male Infertility Market
12.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 13. Company Profile
13.1. Andrology Solutions
13.1.1. Company Snapshot
13.1.2. Business Overview
13.1.3. Financial Overview
13.1.3.1. Revenue (US$ Mn), 2021
13.1.3.2. Andrology solutions2021 Male InfertilityBusiness Regional Distribution
13.1.4. Product/Service Specification
13.1.5. Recent Developments & Business Strategy
13.1.6. ManufacturingPlant Footprint Analysis
13.2. AytuBioScience, Inc.
13.3. Bayer Healthcare
13.4. Cadila Healthcare Ltd.
13.5. EMD Sereno, Inc.
13.6. Halotech DNA SL
13.7. Intas Pharmaceuticals Ltd.
13.8. SCSA Diagnostics, Inc.
Frequently Asked Questions
How much was the estimated value of the global male infertility market in 2021?
The estimated value of global male infertility market in 2021 was accounted to be US$ 3,834 Mn.
What will be the projected CAGR for global male infertility market during forecast period of 2022 to 2030?
The projected CAGR of male infertility market during the analysis period of 2022 to 2030 is 5.0%.
Which are the prominent competitors operating in the market?
The prominent players of the global male infertility market involve Andrology solutions, Halotech DNA SL, AytuBioScience, Inc., Bayer Healthcare, EMD Sereno, Inc., Cadila Healthcare Ltd., SCSA Diagnostics, Inc., and Intas Pharmaceuticals Ltd.
Which region held the dominating position in the global male infertility market?
Europe held the dominating share for male infertility during the analysis period of 2022 to 2030.
Which region exhibited the fastest growing CAGR for the forecast period of 2022 to 2030?
Asia-Pacific region exhibited fastest growing CAGR for male infertility during the analysis period of 2022 to 2030.
What are the current trends and dynamics in the global male infertility market?
Changing lifestyle, high adoption of assisted reproductive technology (ART), and increasing awareness among the people all contribute to the expansion of the worldwide male infertility market.
By segment test, which sub-segment held the maximum share?
Based on test, DNA fragmentation technique segment held the maximum share for male infertility market in 2021.
Select Licence Type
Connect with our sales team
Why Acumen Research And Consulting
100%
Customer Satisfaction
24x7
Availability - we are always there when you need us
200+
Fortune 50 Companies trust Acumen Research and Consulting
80%
of our reports are exclusive and first in the industry
100%
more data and analysis
1000+
reports published till date
